Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Browse
Companies
APR is a Swiss based R&D company offering innovative patent protected products for out-licensing as well as integrated and centrally managed R&D services on a contract basis. More
The worldwide leader in market research publications, advisory services and consulting More
TPU focuses on innovative drug delivery technologies. For companies looking for product-life-cycle extension or a new drug delivery system, we are the strategic partner of choice. More
Par Pharmaceutical Companies, Inc. is a U.S.-based company that develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets. More
QMUL aims to create social and economic benefits for society by developing a culture of innovation and enterprise that will facilitate the commercial exploitation of academic research and technology. More
The Deutsche Krebsforschungszentrum (DKFZ) Heidelberg was founded as a non-profit organization and supraregional research center by the Land (state) Baden-Württemberg in 1964. More
We make your product a success - Boehringer Ingelheim provides highly attentive partnering that ensures enhanced value in all activities to fulfill your aspirations. More
Replizyme is a service and contract research company specialising in viral enzyme targets and predictive toxicity services to pharmaceutical and biotechnology markets More
Good Biotech Corporation (GBC) is a leading producer of industrial scale high-purity polyclonal IgY(-Fc) antibodies from duck egg yolk, offering a wide range of biotechnology applications. More
Your selection
Browse By
- Industry sector
- Academic/Research
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Non-profit org./Government
- Pharmaceutical
- Research tools
- Service
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us